For instance, the simultaneous inhibition of TIGIT and PD-L1 synergized to enhance tumor-infiltrating CD8+ T lymphocyte functions and promoted the rejection of transplanted tumors both in a colon cancer xenograft mouse model and in a syngeneic murine model of breast carcinoma [72]. This evidence concerns the gene CD8A and neoplasm.